Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients

Bristol Myers Squibb and Johnson & Johnson have begun a series of large studies testing a closely watched experimental blood-thinning medicine, setting plans to include almost 50,000 patients.